In the context of lung carcinoma, Chang et al. have shown that artificial modification of type I collagen rigidity in a 2D coating model was able to increase the expression of EGFR in A549 cells, and to induce consequently resistance to erlotinib (8). This evidence concerns the gene EGFR and lung carcinoma.